Sample no. | Subject | Age | Sex | Post mortem time (min) | Braak stage | Seizure | Relative ratio (protein/tubulin) | ||
---|---|---|---|---|---|---|---|---|---|
Actin | APP | HCN1 | |||||||
1 | Normal | 84 | F | 877 | 1 | - | 0.929 | 1.192 | 0.809 |
2 | Normal | 88 | F | 144 | 1 | - | 0.856 | 1.046 | 0.859 |
3 | Normal | 70 | M | 340 | 0.5 | - | 0.955 | 1.189 | 0.859 |
4 | AD | 84 | M | 71 | 4 | - | 0.950 | 1.171 | 0.952 |
5 | AD | 70 | M | 276 | 4 | - | 0.829 | 0.986 | 0.716 |
6 | AD | 74 | M | 322 | 5 | - | 0.961 | 0.990 | 0.827 |
7 | AD | 75 | M | 594 | 6 | - | 1.069 | 1.176 | 0.589 |
8 | AD | 76 | M | 947 | 6 | + | 1.190 | 1.167 | 0.273 |
9 | AD | 79 | F | 203 | 5 | - | 1.019 | 0.913 | 0.317 |
10 | AD | 81 | M | 360 | 6 | - | 0.971 | 0.862 | 0.247 |
11 | AD | 81 | F | 442 | 5 | - | 0.971 | 0.862 | 0.385 |
12 | AD | 82 | F | 254 | 6 | - | 0.988 | 1.029 | 0.313 |
13 | AD | 82 | F | 533 | 5 | - | 0.988 | 1.001 | 0.566 |
14 | AD | 82 | F | 338 | 4 | - | 1.028 | 1.063 | 0.770 |
15 | AD | 84 | M | 590 | 5 | - | 1.071 | 1.128 | 0.876 |
16 | Normal | 78 | F | 87 | 2 | - | 1.108 | 1.138 | 2.153 |
17 | Normal | 81 | M | 134 | 1 | - | 1.122 | 0.971 | 0.902 |
18 | Normal | 82 | F | 148 | 1 | - | 1.178 | 1.109 | 1.963 |
19 | Normal | 82 | F | 155 | 2 | - | 1.141 | 1.026 | 0.821 |
20 | Normal | 80 | M | 317 | 2 | - | 1.254 | 1.037 | 0.893 |
21 | Normal | 80 | M | 510 | 2 | - | 1.071 | 0.778 | 0.669 |
22 | Normal | 82 | M | 530 | 1 | - | 0.979 | 0.916 | 0.384 |
23 | Normal | 78 | M | 575 | 1 | - | 0.905 | 1.007 | 0.713 |
24 | Normal | 78 | M | 690 | 1 | - | 0.784 | 0.986 | 1.479 |
25 | Normal | 82 | M | 736 | 1 | - | 0.774 | 0.743 | 1.448 |